Results 181 to 190 of about 156,187 (258)

Meta‐Analysis: Prevalence of Non‐Helicobacter pylori, Non‐NSAID Peptic Ulcer Disease

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 8, Page 1034-1045, October 2026.
A meta‐analysis of 92 studies including 60,816 patients found that non‐H. pylori, non‐NSAID represent a non‐negligible but heterogeneous component of peptic ulcer disease. Among bleeding ulcers, this proportion increased over time, potentially reflecting evolving etiologic patterns beyond H. pylori infection and NSAID exposure.
Jun Watanabe, Hiromi Sekiguchi, Takeshi Kanno, Keigo Misawa, Satoshi Sato, Yuhong Yuan, Paul Moayyedi, Tomonori Yano, Atsushi Masamune, Tomoari Kamada   +9 more
wiley   +1 more source

Corrigendum to Helicobacter pylori-induced PPFIA4 orchestrates immune network-promoting gastritis and gastric bacterial colonization. [PDF]

J Clin Invest
Wang P, You N, Teng YS, Lv YP, Tian WQ, Xu JY, Xie R, Wu JB, Yue GY, Cheng P, Zhang JY, Peng LS, Mao FY, Luo SL, Yang SM, Zhao YL, Zhou H, Chen W, Wang B, Zhuang Y.   +19 more
europepmc   +1 more source

Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision‐Making

European Journal of Haematology, Volume 117, Issue 4, Page 849-863, October 2026.
ABSTRACT Extranodal marginal zone lymphoma (EMZL) represents a unique paradigm among indolent B‐cell neoplasms, in which lymphomagenesis is frequently driven by chronic antigenic stimulation within tissue‐specific microenvironments. Persistent infectious or autoimmune triggers promote the development of ectopic lymphoid tissue and sustain B‐cell ...
Mamdouh Skafi, Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Marco Fiorillo, Eugenio Lucia, Graziella D'Arrigo, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Maria Eugenia Alvaro, Giovanni Tripepi, Fortunato Morabito, Massimo Gentile   +15 more
wiley   +1 more source

Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality. [PDF]

J Gastroenterol Hepatol
Jung YS, Jeon S, Park B, Moon CM.
europepmc   +1 more source

Spotlight on the Nucleotide: Solid‐State NMR for the Investigation of ATP Hydrolysis in the ATPase SmsC

Chemistry – A European Journal, Volume 32, Issue 34, 11 September 2026.
Nucleotide‐detected solid‐state NMR has been applied to probe nucleotide conformations and dynamics during ATP hydrolysis using the dimeric P‐loop ATPase SmsC as a model protein. The different stages of ATP hydrolysis have been mimicked by ATP analogues for which different degrees of conformational heterogeneity have been observed. ABSTRACT Solid‐state
Nina Wehr, Laure Decamps, Julius Schlüter, Koen Linssen, Georg Künze, Kushal Sengupta, Serena DeBeer, Thomas Wiegand   +7 more
wiley   +1 more source

A Novel Helicobacter pylori Test Based on 16S rRNA Isothermal Amplification Point-of-Care Testing of Throat Swab. [PDF]

Helicobacter
Liu Z, Wu M, Li Y, Huang Q, Mao Z, Diao Y, Yang H, Liu Y, Xie C, Yu Z.   +9 more
europepmc   +1 more source

Lost in the Vaso‐Occlusion: A Patient's Abdominal Pain Returns With a Vengeance

Pediatric Blood &Cancer, Volume 73, Issue 11, November 2026.
Dunia Hatabah, Martha E. Stewart, Nathan Maassel, James P. Stevens, Claudia R. Morris, Chris A. Rees   +5 more
wiley   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, Volume 38, Issue 51, 11 September 2026.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Screening of putative inhibitors for cytotoxin VacA from Helicobacter pylori. [PDF]

Sci Rep
Liu C, Ji C.
europepmc   +1 more source

Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity

Advanced Science, Volume 13, Issue 50, 7 September 2026.
Carnosic acid selectively eradicates drug‐resistant Helicobacter pylori through a multi‐targeted mechanism involving urease inhibition, membrane disruption, and biofilm eradication. It exhibits no detectable resistance, potent in vivo efficacy, and minimal impact on gut microbiota, positioning it as a promising narrow‐spectrum lead compound against ...
Yuefan Bai, Hongming Huang, Xudong Hang, Shanwei Hu, Qian Tong, Jingchen Xu, Jia Jia, Hongkai Bi   +7 more
wiley   +1 more source